Disease Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
Precursor B-cell lymphoblastic leukemia
0.010 GeneticVariation BEFREE Furthermore, we show that primary ALL mononuclear cells harboring the JAK2 R938Q mutation display reduced sensitivity to the JAK1/2 ATP-competitive inhibitor ruxolitinib in vitro, compared to ALL cells that carry a more common JAK2 pseudokinase domain mutation. 29025600 2017